Cargando…

Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)

5′- and 3′-untranslated regions (UTRs) are important regulators of gene expression and play key roles in disease progression and susceptibility. The 5′-UTR of the fragile X mental retardation 1 (FMR1) gene contains a CGG repeat element that is expanded (>200 CGG repeats; full mutation) and methyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tassone, Flora, De Rubeis, Silvia, Carosi, Chiara, La Fata, Giorgio, Serpa, Gisele, Raske, Christopher, Willemsen, Rob, Hagerman, Paul J., Bagni, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152321/
https://www.ncbi.nlm.nih.gov/pubmed/21478165
http://dx.doi.org/10.1093/nar/gkr100
_version_ 1782209753286443008
author Tassone, Flora
De Rubeis, Silvia
Carosi, Chiara
La Fata, Giorgio
Serpa, Gisele
Raske, Christopher
Willemsen, Rob
Hagerman, Paul J.
Bagni, Claudia
author_facet Tassone, Flora
De Rubeis, Silvia
Carosi, Chiara
La Fata, Giorgio
Serpa, Gisele
Raske, Christopher
Willemsen, Rob
Hagerman, Paul J.
Bagni, Claudia
author_sort Tassone, Flora
collection PubMed
description 5′- and 3′-untranslated regions (UTRs) are important regulators of gene expression and play key roles in disease progression and susceptibility. The 5′-UTR of the fragile X mental retardation 1 (FMR1) gene contains a CGG repeat element that is expanded (>200 CGG repeats; full mutation) and methylated in fragile X syndrome (FXS), the most common form of inherited intellectual disability (ID) and known cause of autism. Significant phenotypic involvement has also emerged in some individuals with the premutation (55–200 CGG repeats), including fragile X-associated premature ovarian insufficiency (FXPOI) in females, and the neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), in older adult carriers. Here, we show that FMR1 mRNA in human and mouse brain is expressed as a combination of multiple isoforms that use alternative transcriptional start sites and different polyadenylation sites. Furthermore, we have identified a novel human transcription start site used in brain but not in lymphoblastoid cells, and have detected FMR1 isoforms generated through the use of both canonical and non-canonical polyadenylation signals. Importantly, in both human and mouse, a specific regulation of the UTRs is observed in brain of FMR1 premutation alleles, suggesting that the transcript variants may play a role in premutation-related pathologies.
format Online
Article
Text
id pubmed-3152321
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-31523212011-08-08 Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†) Tassone, Flora De Rubeis, Silvia Carosi, Chiara La Fata, Giorgio Serpa, Gisele Raske, Christopher Willemsen, Rob Hagerman, Paul J. Bagni, Claudia Nucleic Acids Res RNA 5′- and 3′-untranslated regions (UTRs) are important regulators of gene expression and play key roles in disease progression and susceptibility. The 5′-UTR of the fragile X mental retardation 1 (FMR1) gene contains a CGG repeat element that is expanded (>200 CGG repeats; full mutation) and methylated in fragile X syndrome (FXS), the most common form of inherited intellectual disability (ID) and known cause of autism. Significant phenotypic involvement has also emerged in some individuals with the premutation (55–200 CGG repeats), including fragile X-associated premature ovarian insufficiency (FXPOI) in females, and the neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS), in older adult carriers. Here, we show that FMR1 mRNA in human and mouse brain is expressed as a combination of multiple isoforms that use alternative transcriptional start sites and different polyadenylation sites. Furthermore, we have identified a novel human transcription start site used in brain but not in lymphoblastoid cells, and have detected FMR1 isoforms generated through the use of both canonical and non-canonical polyadenylation signals. Importantly, in both human and mouse, a specific regulation of the UTRs is observed in brain of FMR1 premutation alleles, suggesting that the transcript variants may play a role in premutation-related pathologies. Oxford University Press 2011-08 2011-04-07 /pmc/articles/PMC3152321/ /pubmed/21478165 http://dx.doi.org/10.1093/nar/gkr100 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle RNA
Tassone, Flora
De Rubeis, Silvia
Carosi, Chiara
La Fata, Giorgio
Serpa, Gisele
Raske, Christopher
Willemsen, Rob
Hagerman, Paul J.
Bagni, Claudia
Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)
title Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)
title_full Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)
title_fullStr Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)
title_full_unstemmed Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)
title_short Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles(†)
title_sort differential usage of transcriptional start sites and polyadenylation sites in fmr1 premutation alleles(†)
topic RNA
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152321/
https://www.ncbi.nlm.nih.gov/pubmed/21478165
http://dx.doi.org/10.1093/nar/gkr100
work_keys_str_mv AT tassoneflora differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT derubeissilvia differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT carosichiara differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT lafatagiorgio differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT serpagisele differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT raskechristopher differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT willemsenrob differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT hagermanpaulj differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles
AT bagniclaudia differentialusageoftranscriptionalstartsitesandpolyadenylationsitesinfmr1premutationalleles